The public funds made available for the ROCK-ALS study cover all procedures of the clinical trial, but unfortunately individual patient accommodation or patient transport to the study centre cannot be covered in a study budget. The analysis of biomarkers that go beyond this, which give us even more detailed information on whether our therapy has been effective and which patients benefit most from it, is also beyond the study budget. We therefore ask for donations to enable all patients to participate in this clinical trial and to analyse biomarkers.

Help us with the donation account of the

Universitätsmedizin Göttingen
IBAN: DE98 2605 0001 0000 0014 20
BIC: NOLADE21GOE
Verwendungszweck: ROCK-ALS-Studie

http://www.med.uni-goettingen.de/de/content/service/26300.html

We would like to thank the following donors for their support of our project:

– Diagnose ALS was nun e.V.
– Gerhard Loeb
– Klaus Lück
– Dr. Hubert Jäger
– Karlheinz Rufener
– Dr. Huschang Saradj
– Bernhard Meerpohl
– Sparkasse Göttingen
– Stiftung für medizinische Wissenschaft
– Symrise AG
– Refratechnik Cement GmbH
– Paracelcus-Elena-Klinik
– Wohnungsgenossenschaft eG Göttingen
– Christian Wulff, Bundespräsident a. D.
– NT Nordwestdeutsche Treuhand GmbH
– Ralf O. H. Kähler
– Dr. Hans-Rudolf Kurth
– Krüger Internationale Spedition GmbH
– Bandelow & Uhlendorff, Garten- und Landschaftsbau
– ASC Göttingen von 1846 e.V.
– EnergieNetz Mitte GmbH
– Micheel – Das Küchenstudio GmbH
– Nordzucker AG
– Gethke Glas Göttingen GmbH & Co. KG

With your donation, you have made an important contribution to improving the feasibility of the study. We thank you very much for that!